Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    IMUC

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
0.48(c) 0.47(c) 0.4721(c) 0.48(c) 0.4799(c) Last
315 928 240 665 150 131 698 591 67 528 Volume
-2.70% -2.08% +0.45% +1.67% -0.02% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -15,7 M
Net income 2015 -14,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 -
EBIT 2016 -21,5 M
Net income 2016 -21,6 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 0
Capitalization 43,3 M
More Financials
Company
ImmunoCellular Therapeutics Ltd. is a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of cancers.Immunotherapy is an emerging approach to treating cancer in which a patients own immune system is stimulated to target tumor antigens, which are... 
More about the company
Latest news on IMMUNOCELLULAR THERAPEUTIC
07/23 IMMUNOCELLULAR THERAPEUTICS : to Report Second Quarter 2015 Financial Results on..
07/06 IMMUNOCELLULAR THERAPEUTICS : Establishes Agreement with Novella Clinical to Con..
07/02 IMMUNOCELLULAR THERAPEUTICS : Submission of Matters to a Vote of Security Holder..
07/01 IMMUNOCELLULAR THERAPEUTICS : Establishes Agreement with Pure MHC for Novel Qual..
06/29 IMMUNOCELLULAR THERAPEUTICS : to Present at Cantor Fitsgerald Inaugural Healthca..
06/24 IMMUNOCELLULAR THERAPEUTICS : Enters into Manufacturing Agreement with PCT LLC, ..
06/23 IMMUNOCELLULAR THERAPEUTICS : Enters into Agreement with Pure MHC
06/22 IMMUNOCELLULAR THERAPEUTICS : Establishes Agreement with Pure MHC for Novel Qual..
More news
Sector news : Biotechnology & Medical Research - NEC
07/31 QUINTILES TRANSNATIONAL : Announces Pricing of Secondary Public Offering
07/30 SEATTLE GENETICS : reports 2Q loss
07/30 QUINTILES TRANSNATIONAL : Announces Launch of Secondary Public Offering of Commo..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/22 NEXT WEEK IN BIOTECH : Salix/Valeant PDUFA, ASCO, Brain Tumor Summit
05/19 Immunocellular Therapeutics amends license agreement with Cedars-Sinai
05/12 ImmunoCellular's (IMUC) CEO Andrew Gengos on Q1 2015 Results - Earnings Call ..
05/12 ImmunoCellular Therapeutics net loss improves in Q1
05/11 ImmunoCellular Therapeutics beats by $0.01


Comments 
Advertisement
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions